Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Zhonglian Group Sifang Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and modern chemical drugs. As a subsidiary of the larger Wuhan Zhonglian Pharmaceutical Group (which is part of the China Meheco Group), the company focuses on a diverse portfolio including gastrointestinal treatments, respiratory medications, and cardiovascular health products. Its facilities are equipped for large-scale production of various dosage forms such as tablets, capsules, and granules. The company integrates traditional herbal expertise with modern pharmaceutical standards to serve the domestic Chinese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Zhonglian Group Sifang Pharmaceutical.